Cross‐talk between CFTR and sphingolipids in cystic fibrosis
Cystic fibrosis (CF) is the most common inherited, life‐limiting disorder in Caucasian populations. It is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), which lead to an impairment of protein expression and/or function. CFTR is a chloride/bic...
Main Authors: | Dorina Dobi, Nicoletta Loberto, Rosaria Bassi, Anna Pistocchi, Giulia Lunghi, Anna Tamanini, Massimo Aureli |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-09-01
|
Series: | FEBS Open Bio |
Subjects: | |
Online Access: | https://doi.org/10.1002/2211-5463.13660 |
Similar Items
-
GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease
by: Giulia Mancini, et al.
Published: (2020-06-01) -
Functional Consequences of CFTR Interactions in Cystic Fibrosis
by: Yashaswini Ramananda, et al.
Published: (2024-03-01) -
Editorial: Bioactive sphingolipids in health and disease
by: Mutay Aslan, et al.
Published: (2022-10-01) -
Cystic Fibrosis, CFTR, and Colorectal Cancer
by: Patricia Scott, et al.
Published: (2020-04-01) -
Thematic Review Series: Sphingolipids. Nuclear sphingolipids: metabolism and signaling*
by: Robert W. Ledeen, et al.
Published: (2008-06-01)